ArticleAIDS and behavior2026
A Decade of HIV Pre-Exposure Prophylaxis (PrEP) Cascade Monitoring: National Trends and Persistent Gaps in PrEP Use Among Gay, Bisexual and Queer Men and Non-Binary People in Australia.
Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We have monitored Australia's maturing HIV pre-exposure prophylaxis (PrEP) program for the past decade, providing a unique view of long-term implementation among gay, bisexual and queer men and non-binary people. Using two national surveys, the GBQ + Community Periodic Surveys (GCPS, 2014-2023, N = 78,378) and the PrEPARE Project (2017-2023, N = 5,278), we constructed and iteratively refined cascades to monitor PrEP suitability, awareness, use, and service engagement. The PrEPARE cascade also included willingness, provider engagement and psychosexual benefits of PrEP. By 2023, both cascades showed near-universal PrEP awareness among PrEP-suitable participants. In the GCPS cascade, PrEP use increased from < 1% of PrEP-suitable participants in 2014 to 30% in 2023, while in PrEPARE it increased from 21% in 2017 to 46% in 2023. However, in 2023, 29% of GCPS participants who were suitable and aware were not using PrEP, and 14% of PrEPARE participants who were PrEP-suitable and aware were unwilling to use it. PrEP use was lower among younger participants, bisexual and queer-identified participants compared with gay-identified participants, those outside metropolitan areas, and migrants without government-subsidised healthcare. Australia is among the few countries with repeated PrEP cascades that have been revised as implementation has evolved. We show that Australia has achieved near-universal PrEP awareness but highlight persistent inequities in uptake. Our findings demonstrate the value of long-term cascade monitoring and the need to address financial, geographic, and risk-perception barriers to close remaining gaps.
Indexed as
Identifiers
41843254What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.